Cummings, J., Arnold, V., Yarbrough, K., Didier, C., Levy, Y., Barré-Sinoussi, F., & Scott-Algara, D. (2009). OA02-06 LB. Recombinant modified Vaccinia virus ankara expressing HIV-1 genes activates NK subset capable of controlling HIN infection in vitro. BioMed Central.
Citação norma ChicagoCummings, J., V. Arnold, K. Yarbrough, C. Didier, Y. Levy, F. Barré-Sinoussi, and D. Scott-Algara. OA02-06 LB. Recombinant Modified Vaccinia Virus Ankara Expressing HIV-1 Genes Activates NK Subset Capable of Controlling HIN Infection in Vitro. BioMed Central, 2009.
MLA引文Cummings, J., et al. OA02-06 LB. Recombinant Modified Vaccinia Virus Ankara Expressing HIV-1 Genes Activates NK Subset Capable of Controlling HIN Infection in Vitro. BioMed Central, 2009.